Lombard Medical Inc
OTC:EVARF
Lombard Medical Inc
OTC:EVARF
Price:
0.0001
USD
Market Closed
Market Cap:
$28
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lombard Medical Inc
OTC:EVARF
|
UK |
|
S
|
Sanofi SA
XBER:SNW
|
FR |
|
Anabuki Kosan Inc
TSE:8928
|
JP |
|
Y
|
York Space Systems Inc
NYSE:YSS
|
US |
|
C
|
China Fishery Group Ltd
SGX:B0Z
|
HK |
|
D
|
DigiMax Global Inc
OTC:DBKSF
|
CA |
Income Statement
Earnings Waterfall
Lombard Medical Inc
Lombard Medical Inc
Income Statement
Lombard Medical Inc
Lombard Medical Inc
Currency: USD
| Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Revenue |
8
N/A
|
11
+33%
|
13
+23%
|
15
+10%
|
17
+16%
|
17
0%
|
15
-11%
|
15
-3%
|
14
-5%
|
13
-9%
|
12
-4%
|
|
| Gross Profit | ||||||||||||
| Cost of Revenue |
(5)
|
(6)
|
(8)
|
(8)
|
(9)
|
(9)
|
(8)
|
(8)
|
(10)
|
(10)
|
(11)
|
|
| Gross Profit |
3
N/A
|
5
+36%
|
6
+26%
|
7
+15%
|
8
+20%
|
8
+3%
|
7
-17%
|
6
-9%
|
4
-31%
|
3
-40%
|
1
-56%
|
|
| Operating Income | ||||||||||||
| Operating Expenses |
(33)
|
(37)
|
(40)
|
(45)
|
(44)
|
(45)
|
(46)
|
(43)
|
(40)
|
(36)
|
(27)
|
|
| Selling, General & Administrative |
(25)
|
(28)
|
(31)
|
(34)
|
(33)
|
(34)
|
(35)
|
(32)
|
(29)
|
(26)
|
(19)
|
|
| Research & Development |
(8)
|
(9)
|
(9)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
(11)
|
(10)
|
(8)
|
|
| Operating Income |
(30)
N/A
|
(33)
-11%
|
(35)
-6%
|
(39)
-12%
|
(36)
+8%
|
(36)
-2%
|
(39)
-8%
|
(37)
+6%
|
(36)
+3%
|
(33)
+7%
|
(26)
+23%
|
|
| Pre-Tax Income | ||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
|
| Non-Reccuring Items |
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(3)
|
|
| Pre-Tax Income |
(31)
N/A
|
(34)
-10%
|
(36)
-6%
|
(39)
-7%
|
(36)
+7%
|
(37)
-3%
|
(40)
-9%
|
(38)
+5%
|
(38)
0%
|
(36)
+5%
|
(33)
+10%
|
|
| Net Income | ||||||||||||
| Tax Provision |
1
|
2
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
1
|
1
|
|
| Income from Continuing Operations |
(30)
|
(32)
|
(35)
|
(37)
|
(35)
|
(34)
|
(38)
|
(36)
|
(36)
|
(35)
|
(31)
|
|
| Net Income (Common) |
(30)
N/A
|
(32)
-10%
|
(35)
-7%
|
(37)
-8%
|
(35)
+8%
|
(34)
+0%
|
(38)
-10%
|
(36)
+5%
|
(36)
0%
|
(35)
+3%
|
(31)
+11%
|
|
| EPS (Diluted) |
-2.28
N/A
|
-2
+12%
|
-2.39
-20%
|
-2.31
+3%
|
-2.13
+8%
|
-1.84
+14%
|
-2.13
-16%
|
-1.8
+15%
|
-1.8
N/A
|
-1.76
+2%
|
-1.54
+12%
|
|
Switch to:
Switch to:
See Also
Discover More
